Market Insights Health Pharmacies OTC Products

Digestive & Intestinal Remedies (Pharmacies) - Spain

Spain

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$0.39bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.47%, resulting in a market volume of US$0.43bn by 2028.
In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
In relation to total population figures, per person revenues of US$8.19 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Spain has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Spain have played a key role in the growth of the Digestive & Intestinal Remedies market. Spaniards are becoming increasingly health-conscious and are seeking remedies for digestive and intestinal issues. This shift in consumer behavior has led to a higher demand for products in this market segment. Trends in the market have also contributed to its growth. The Digestive & Intestinal Remedies market in Spain has seen an increase in the availability of over-the-counter products. This has made it easier for consumers to access remedies for their digestive and intestinal issues without the need for a prescription. Additionally, there has been a rise in the use of natural and herbal remedies, as consumers are becoming more interested in alternative medicine. Local special circumstances have played a role in the development of the Digestive & Intestinal Remedies market in Spain. The country has a high prevalence of digestive and intestinal issues, which has created a strong demand for remedies. This, coupled with the increasing health-consciousness of the population, has created a favorable environment for the growth of this market. Underlying macroeconomic factors have also contributed to the development of the Digestive & Intestinal Remedies market in Spain. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income. This has allowed consumers to spend more on healthcare products, including remedies for digestive and intestinal issues. In conclusion, the Digestive & Intestinal Remedies market in Spain has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing health-consciousness of consumers, the availability of over-the-counter products, the use of natural and herbal remedies, the high prevalence of digestive and intestinal issues, and the steady economic growth in the country have all contributed to the development of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.